Literature DB >> 21911529

Total hip replacement for high dislocated hips without femoral shortening osteotomy.

X Zhao1, Z-A Zhu, Y-Z Xie, B Yu, D-G Yu.   

Abstract

When performing total hip replacement (THR) in high dislocated hips, the presence of soft-tissue contractures means that most surgeons prefer to use a femoral shortening osteotomy in order to avoid the risk of neurovascular damage. However, this technique will sacrifice femoral length and reduce the extent of any leg-length equalisation. We report our experience of 74 THRs performed between 2000 and 2008 in 65 patients with a high dislocated hip without a femoral shortening osteotomy. The mean age of the patients was 55 years (46 to 72) and the mean follow-up was 42 months (12 to 78). All implants were cementless except for one resurfacing hip implant. We attempted to place the acetabular component in the anatomical position in each hip. The mean Harris hip score improved from 53 points (34 to 74) pre-operatively to 86 points (78 to 95) at final follow-up. The mean radiologically determined leg lengthening was 42 mm (30 to 66), and the mean leg-length discrepancy decreased from 36 mm (5 to 56) pre-operatively to 8.5 mm (0 to 18) postoperatively. Although there were four (5%) post-operative femoral nerve palsies, three had fully resolved by six months after the operation. No loosening of the implant was observed, and no dislocations or infections were encountered. Total hip replacement without a femoral shortening osteotomy proved to be a safe and effective surgical treatment for high dislocated hips.

Entities:  

Mesh:

Year:  2011        PMID: 21911529     DOI: 10.1302/0301-620X.93B9.25914

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  8 in total

1.  Results of total hip arthroplasty differ in subtypes of high dislocation.

Authors:  George Hartofilakidis; George C Babis; Kalliopi Lampropoulou-Adamidou; John Vlamis
Journal:  Clin Orthop Relat Res       Date:  2013-04-10       Impact factor: 4.176

2.  Lesser trochanteric osteotomy in total hip arthroplasty for treating CROWE type IV developmental dysplasia of hip.

Authors:  Nirong Bao; Jia Meng; Liwu Zhou; Ting Guo; Xiaofeng Zeng; Jianning Zhao
Journal:  Int Orthop       Date:  2013-01-05       Impact factor: 3.075

3.  Total hip arthroplasty with subtrochanteric osteotomy in neglected dysplastic hip.

Authors:  Eid Ahmed; El-Ganzoury Ibrahim; Bassiony Ayman
Journal:  Int Orthop       Date:  2014-10-11       Impact factor: 3.075

4.  Partial greater trochanter osteotomy for hip reduction in total hip arthroplasty for high dislocated hip: a preliminary report.

Authors:  Rui Yu Liu; Chuan Yi Bai; Qi Chun Song; Xiao Qian Dang; Yao Jun Wu; Kun Zheng Wang
Journal:  BMC Musculoskelet Disord       Date:  2014-09-04       Impact factor: 2.362

5.  Cementless Total Hip Arthroplasty Involving Trochanteric Osteotomy without Subtrochanteric Shortening for High Hip Dislocation.

Authors:  Soong Joon Lee; Jeong Joon Yoo; Hee Joong Kim
Journal:  Clin Orthop Surg       Date:  2017-02-13

6.  Restoration of Proximal Femoral Anatomy during Total Hip Arthroplasty for High Developmental Dysplasia of the Hip: An Original Technique.

Authors:  Kerong Wu; Xianzuo Zhang; Min Chen; Xifu Shang
Journal:  Orthop Surg       Date:  2020-02       Impact factor: 2.071

7.  Gait symmetry and hip strength in women with developmental dysplasia following hip arthroplasty compared to healthy subjects: A cross-sectional study.

Authors:  Ruud A Leijendekkers; Marco A Marra; Sjoerd Kolk; Geert van Bon; B Wim Schreurs; Vivian Weerdesteyn; Nico Verdonschot
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

8.  Calculation method to predict postoperative limb length in patients undergoing THA following developmental dysplasia of hips.

Authors:  Renwen Guo; Jerry Yongqiang Chen; Guoqiang Zhang; Yonggang Zhou; Jiying Chen; Wei Chai
Journal:  BMC Musculoskelet Disord       Date:  2019-11-03       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.